Literature DB >> 2907365

Cloning of the adenylate cyclase genetic determinant of Bordetella pertussis and its expression in Escherichia coli and B. pertussis.

R M Brownlie1, J G Coote, R Parton, J E Schultz, A Rogel, E Hanski.   

Abstract

A recombinant plasmid, pRMB1, identified from a gene library of B. pertussis, restored adenylate cyclase (AC) and haemolysin (HLY) activities to B. pertussis BP348 (a Tn5-insertion mutant deficient in both these activities). B. pertussis BP348 was considerably less virulent than wild type strains of B. pertussis when 3-week-old mice were challenged intranasally; possession of pRMB1 restored virulence. Neither AC nor HLY activities were expressed in E. coli harbouring pRMB1. However, expression of calmodulin-responsive AC was obtained in E. coli when restriction fragments of pRMB1 were subcloned into other vectors; expression depended on the lac and tac promoters of these vectors. The enzyme was not readily solubilized from urea extracts of E. coli and required sonication for efficient release. One plasmid conferred a specific AC enzymic activity to E. coli which was greater than that for wild type B. pertussis strains. Unlike extracts of B. pertussis, extracts from E. coli expressing enzymic AC activity, did not elevate cAMP levels in S49 lymphoma cells. A second plasmid, pRMB2, was identified from the gene library, which contained a trans-acting regulatory determinant required for expression of AC, HLY and other virulence-associated factors in B. pertussis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907365     DOI: 10.1016/0882-4010(88)90061-7

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  11 in total

1.  Stimulation of Bordetella pertussis adenylate cyclase toxin intoxication by its hemolysin domain.

Authors:  M Iwaki; K Kamachi; T Konda
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Structure-function studies of the adenylate cyclase toxin of Bordetella pertussis and the leukotoxin of Pasteurella haemolytica by heterologous C protein activation and construction of hybrid proteins.

Authors:  G Westrop; K Hormozi; N da Costa; R Parton; J Coote
Journal:  J Bacteriol       Date:  1997-02       Impact factor: 3.490

3.  Synthesis and secretion of Bordetella pertussis adenylate cyclase as a 200-kilodalton protein.

Authors:  J Bellalou; D Ladant; H Sakamoto
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

4.  Construction of minitransposons for constitutive and inducible expression of pertussis toxin in bvg-negative Bordetella bronchiseptica.

Authors:  M J Walker; M Rohde; J Wehland; K N Timmis
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Suppression of platelet aggregation by Bordetella pertussis adenylate cyclase toxin.

Authors:  M Iwaki; K Kamachi; N Heveker; T Konda
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion.

Authors:  M Mouallem; Z Farfel; E Hanski
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

7.  Direct expression of Bordetella pertussis filamentous hemagglutinin in Escherichia coli and Salmonella typhimurium aroA.

Authors:  C A Guzmán; M J Walker; M Rohde; K N Timmis
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

8.  Dissociation of catalytic and invasive activities of Bordetella pertussis adenylate cyclase.

Authors:  A Raptis; L Knipling; J Wolff
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

9.  Effect of methyl-cyclodextrin on adenylate cyclase activity of Bordetella pertussis.

Authors:  D F Hozbor; A Samo; O M Yantorno
Journal:  World J Microbiol Biotechnol       Date:  1991-05       Impact factor: 3.312

10.  Expression of contact-dependent cytolytic activity by Mycobacterium tuberculosis and isolation of the genomic locus that encodes the activity.

Authors:  C H King; S Mundayoor; J T Crawford; T M Shinnick
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.